MOTS-c Peptide: What It Is, What It Does, and Why Labs Are Studying It

If you have been reading about mitochondria, metabolism, or aging research, you have probably come across MOTS-c peptide. It is one of the most exciting discoveries in peptide research.

Most peptides are made from nuclear DNA. MOTS-c is a unique peptide. It is made from mitochondrial DNA. That makes it rare and gives it a unique role in the body’s energy management.

Scientists discovered MOTS-c in 2015. Since then, lab studies have linked it to improved metabolism, greater insulin sensitivity, enhanced physical performance, and slower ageing in animal models.

This guide covers everything researchers need to know about MOTS-c peptides: what they are, how they work, what the studies say, and how they are used in lab settings.

What Is MOTS-c Peptide?

The name MOTS-c refers to the Mitochondrial Open Reading Frame of the 12S rRNA-c. It is a short peptide made of 16 amino acids.

Here is what makes it special: almost all known peptides are encoded by nuclear DNA. MOTS-c is encoded by mitochondrial DNA, specifically the 12S ribosomal RNA region. That is a very rare thing.

Mitochondria are small structures inside your cells. Most people know them as the “powerhouse of the cell” because they produce ATP, the energy your cells run on. What most people do not know is that mitochondria have their own DNA, separate from the DNA in your cell nucleus. MOTS-c comes from that separate mitochondrial DNA.

The peptide was discovered in 2015 by Lee et al., who published it in Cell Metabolism ⁽¹⁾. That study found MOTS-c could reduce obesity and insulin resistance in mice. Since then, research has expanded into aging, exercise, heart health, and more.

Quick Facts about MOTS-c

• Length: 16 amino acids
• Source: Mitochondrial DNA, specifically the 12S rRNA gene
• Discovery: 2015, Lee et al., Cell Metabolism
• Also known as: Mots-c peptide, Mots-c, Mot c peptide
• Classification: Mitochondrial-derived peptide (MDP)

Under normal conditions, MOTS-c stays inside the mitochondria. However, when the body is stressed, such as during fasting or exercise, MOTS-c moves out of the mitochondria and into the cell nucleus. Once there, it helps regulate genes that control energy metabolism and cell survival.

Scientists call this bi-genomic signalling. It means that two different genomes (nuclear DNA and mitochondrial DNA) work together to keep the body balanced. MOTS-c is a key part of that process.

How does the MOTS-c peptide function?

MOTS-c performs its function through a few interconnected pathways. Understanding these pathways helps explain why it appears in so many areas of research.

It activates AMPK

AMPK stands for AMP-activated protein kinase. It is often described as the “master regulator” of cellular energy metabolism. When AMPK turns on, the body responds in several ways:

• Cells take in more glucose for energy
• The body burns more fat
• Mitochondria multiply (a process called biogenesis)
• Energy-wasting processes slow down

MOTS-c triggers this AMPK switch. That is why researchers often compare its effects to those of exercise or fasting; it sends some of the same signals at the cellular level.

It moves into the cell nucleus under stress.

When energy is low, during fasting, intense exercise, or caloric restriction, MOTS-c leaves the mitochondria and moves into the nucleus. Inside the nucleus, it binds to DNA and turns on specific genes.

These genes help the cell cope with hard conditions. They manage processes such as the heat shock response (which protects cells under heat or stress) and metabolic flexibility (the ability to switch between burning sugar and fat).

It works through the folate cycle.

MOTS-c also works through a lesser-known pathway. It interferes with the folate cycle in skeletal muscle. This leads to the buildup of a molecule called AICAR, a natural AMPK activator. So MOTS-c activates AMPK through two separate pathways at once, not just one.

It interacts with mTOR

mTOR is another key cellular pathway. It controls cell growth, protein production, and survival. MOTS-c also interacts with mTOR signaling, which helps explain its effects on aging and cell health.

Together, these pathways give MOTS-c a broad reach. One small peptide, multiple entry points into cellular metabolism.

Does the Body Already Make MOTS-c?

Yes, MOTS-c is naturally produced within the human body. It is not something that only exists in a lab vial. However, the key finding from the research is that natural MOTS-c levels vary with body activity and decline significantly with age.

Exercise raises MOTS-c levels.

A landmark 2021 study published in Nature Communications showed that exercise induces a sharp increase in MOTS-c levels in skeletal muscle. Levels in circulation also rise, but they return to baseline within about four hours after exercise ends.

This makes MOTS-c an exercise-induced peptide. Its natural role is helping the body adapt to physical stress.

Levels drop with age and disease.

Research has found that MOTS-c levels are significantly lower in people with:

• Type 2 diabetes
• Diabetes during pregnancy (gestational diabetes)
• Obesity
• Coronary endothelial dysfunction

Levels also decline as people age in general. This age-related drop is why MOTS-c has become a major focus in longevity research. Restoring those levels experimentally in animal studies has produced notable results.

Think of MOTS-c as a messenger that your mitochondria send out when the body is under stress. As we age, that messenger gets quieter.

MOTS-c for Energy: What Research Shows

One of the most searched questions about this peptide is whether MOTS-c helps with energy. Based on lab studies, the answer is yes at the cellular level. Current studies suggest the following:

It helps boost ATP generation within cells.

ATP is the fuel your cells use to do everything: move, grow, repair, signal. More ATP means more usable energy at the cellular level.

Cell studies have shown that MOTS-c increases mitochondrial ATP content in senescent human fibroblasts (Kim et al., 2018) and in HEK293 cells (Lee et al., 2015). A 2025 study in Frontiers in Physiology also found that MOTS-c restored mitochondrial respiration in diabetic rat heart tissue, which was unable to efficiently produce energy.

It improves how cells use fuel.

MOTS-c helps cells switch between burning glucose and burning fat. This “metabolic flexibility” is important because cells that are locked into burning only one type of fuel become less efficient over time.

By activating AMPK, MOTS-c pushes cells to burn fat more effectively and absorb glucose more efficiently. The result, in research models, is better overall energy homeostasis, a more balanced energy state.

It mimics what exercise does to cells.

We have described MOTS-c as an “exercise-mimetic”, a compound that recreates some of the cellular effects of physical activity. Like exercise, it activates AMPK, promotes fat burning, and drives mitochondrial biogenesis.

This is why MOTS-c research has attracted interest in fatigue, metabolic disease, and aging, conditions in which the body’s natural energy systems are struggling.

MOTS-c Peptide Benefits in Lab Research

Note: All findings below are from preclinical studies, animal models or cell cultures. MOTS-c is not approved for human use and has not completed full clinical trials.

1. Metabolic health and insulin sensitivity

The original 2015 paper showed MOTS-c reduced insulin resistance and improved glucose metabolism in mice on a high-fat diet. Follow-up studies have confirmed and expanded on this.

• MOTS-c lowered blood glucose in multiple rodent models of type 1 and type 2 diabetes.
• It enhanced fat metabolism and reduced body weight in obese mice, without reducing their food intake, suggesting a direct boost to metabolic rate.
• In 2025, researchers reported findings on MOTS-c in the journal Experimental & Molecular Medicine. The researchers found that it reduced age-related stress in pancreatic beta cells. These cells play a key role in insulin production. The study also reported improved glucose control in diabetic mouse models.

This cluster of findings has made MOTS-c a popular Peptide research tool for scientists studying type 2 diabetes and metabolic syndrome.

2. Exercise performance and muscle health

The 2021 Nature Communications study is one of the most cited in the field. It tested MOTS-c on mice of three age groups: young (2 months), middle-aged (12 months), and old (22 months).

Across all age groups, MOTS-c improved:

• Grip power
• Physical coordination and stability
• Endurance during running

Remarkably, even late-life treatment, initiated at 23.5 months of age in mice, increased physical capacity. The study concluded that MOTS-c regulates skeletal muscle metabolism and can extend healthspan, even when initiated in old age.

Human observational research has supported this. Higher natural MOTS-c levels in people have been linked to greater muscle mass, strength, and jumping power (Domin et al., 2023).

3. Aging and longevity research

This is one of the most active research areas for MOTS-c. The reasons are clear:

• MOTS-c levels naturally decline with age
• Restoring MOTS-c in old mice improved memory, movement, and stress handling
• MOTS-c protects DNA and supports healthy mitochondria, both linked to slower aging
• It prevents beta cell senescence (cellular aging) in the pancreas, which may delay age-related diabetes

Researchers use the term “inflammaging” to describe the low-grade chronic inflammation that builds up as we age. A 2024 study found MOTS-c may help combat this process, too.

4. Heart health research

Lower MOTS-c levels have been found in patients with coronary endothelial dysfunction (Qin et al., 2018). In animal models, MOTS-c has shown:

• Protection against cardiac hypertrophy caused by pressure overload (Zhong et al., 2022)
• Restored mitochondrial respiration in diabetic heart tissue (Frontiers in Physiology, 2025)
• Reduced inflammation and oxidative stress in heart cells

5. Supports Anti-inflammatory Activity

MOTS-c has shown anti-inflammatory properties in several lab settings:

• Reduced inflammatory markers in pancreatic tissue
• Protected against acute lung injury in rodents (Miller et al., 2020)
• Increased survival and cut bacterial load in mice infected with MRSA, a hard-to-treat bacterial infection (Zhai et al., 2017)

6. Emerging research areas

Scientists are now exploring MOTS-c in areas that go beyond metabolism:

• Cancer: A 2024 study in Advanced Science found MOTS-c levels are lower in ovarian cancer patients. Adding MOTS-c to cancer cell cultures slowed their growth, movement, and spread.
• Bone health: MOTS-c promotes bone formation and inhibits bone breakdown, according to studies reviewed in Frontiers in Physiology (2023).
• Sex differences: Research suggests MOTS-c may work differently in men and women. Male models appear to show stronger metabolic benefits. This may be linked to interactions with estrogen.

How MOTS-c Compares to Other Peptides and Compounds

Researchers often ask how MOTS-c fits alongside other well-known peptides. To explain it more clearly:

MOTS-c vs. Metformin

Both activate AMPK. However, they work differently and in different places.

• Metformin primarily acts on the liver
• MOTS-c mainly targets skeletal muscle tissue.
• MOTS-c also moves into the nucleus to regulate genes; metformin does not
• Their side effect profiles may differ, though this has not been fully studied

Comparison between MOTS-c and Humanin

Humanin is another mitochondrial-derived peptide. It has been studied for neuroprotection and some metabolic effects.

• Humanin focuses more on brain and nerve protection
• MOTS-c focuses more on metabolic regulation and physical performance
• Both come from mitochondrial DNA, which is their shared origin

MOTS-c Compared to BPC-157

BPC-157 is studied for tissue repair and gut healing. It has a completely different mechanism from MOTS-c.

• BPC-157 targets wound healing, tendon repair, and gut health
• MOTS-c targets energy metabolism, insulin sensitivity, and aging
• They can be studied in different research contexts without overlap

MOTS-c vs. CJC-1295 and Ipamorelin

These peptides work through the growth hormone pathway. MOTS-c does not have this effect.

• CJC-1295 and Ipamorelin are known to promote growth hormone release.
• MOTS-c works directly through AMPK and mitochondrial signaling
• They target different physiological systems entirely

How MOTS-c Peptide Is Used in Labs

For researchers working with MOTS-c, here is what you need to know about handling and using it in practice.

In which form is it typically available?

Synthetic MOTS-c is supplied as a lyophilized (freeze-dried) powder. It needs to be reconstituted before use.

• For in vivo (animal) studies: reconstitute with sterile bacteriostatic water
• For in vitro (cell culture) studies: reconstitute in appropriate cell culture media

What are the recommended storage conditions?

• Dry powder: Store at −20°C for long-term stability
• Reconstituted: Store at 2–8°C (standard refrigeration)
• Shelf life after mixing: Stable for at least 30 days at 4°C (confirmed by mass spectrometry, Mohtashami et al., 2022)
• Freeze-thaw cycles: Avoid repeated cycles, as they degrade peptide quality

In which form is it typically available?

Dose ranges vary widely across studies, depending on the research goal and duration:

• 0.5 mg/kg: Used in longer studies (8–12 weeks), typically for metabolic endpoints
• 1–5 mg/kg: Common range for metabolic, cardiac, and inflammation research
• 5–15 mg/kg: Used in the 2021 Nature Communications exercise and aging study
• 50 mg/kg: Observed only in specific acute-model studies

Always design dosage around the specific model, endpoint, and duration of your study. Refer to individual published protocols for guidance.

How is it administered in animal studies?

• Intraperitoneal (IP) injection is the most common route in rodent studies
• Subcutaneous injection has been used in some studies, including the CB4211 analog Phase 1 trial

Safety Profile and Research Status of MOTS-c Peptide

Researchers and labs need to understand where MOTS-c stands from a safety and regulatory standpoint.

What preclinical data says

In animal studies, MOTS-c has generally been well tolerated at standard research doses. No major adverse effects were reported in the core metabolic and aging studies.

At higher doses (10–15 mg/kg), some studies have noted the potential for mild injection site reactions and digestive disturbance.

The CB4211 human trial

CB4211 is a synthetic analog of MOTS-c that moved into Phase 1 clinical trials in humans. This is the closest thing to human data available.

• It was found to be safe and well-tolerated after 7 days of dosing in healthy adults.
• The trial was temporarily paused in 2018 due to persistent mild injection site reactions (painless bumps under the skin)
• After an amended protocol, the Phase 1a study resumed and was completed in 2019
• A Phase 1b study in subjects with obesity and fatty liver disease was paused in 2020 due to COVID-19, not safety concerns.

Approval and Regulatory Classification

MOTS-c has not received FDA approval for any therapeutic or medical application. It is not considered a dietary supplement. It cannot be legally sold for human injection.

It is classified as a research-use-only (RUO) compound. Labs working with MOTS-c must follow all applicable institutional and legal safety protocols.

WADA status: MOTS-c is prohibited at all times under the World Anti-Doping Agency’s Prohibited List, under Section 4.4.1 (Activators of AMPK). This applies to competitive athletes regardless of country.

Why Researchers Choose Ignite Peptides for MOTS-c

Getting reliable results in peptide research starts with the quality of the source. Impure or unstable peptides produce inconsistent data. Here is what we offer labs working with MOTS-c:

• Over 99% purity: Confirmed by third-party HPLC and mass spectrometry testing
• Full Certificate of Analysis (COA): Included with every order. Shows purity, identity, and test methodology
• USA shipping: Fast same-day dispatch from the United States
• Research-use labelling: All products are clearly labelled for laboratory use only
• Researcher support: Responsive team available for academic labs, private researchers, and institutions

Closing Summary

The MOTS-c peptide is one of the most studied mitochondrial-derived peptides in research today. It is encoded by mitochondrial DNA, activates AMPK, enters the cell nucleus under stress, and plays a role in energy metabolism, insulin sensitivity, aging, and physical performance.

The research is still growing. New studies in 2024 and 2025 are expanding its potential scope into heart health, cancer biology, and bone metabolism.

For labs looking to work with MOTS-c peptides, Ignite Peptides provides high-purity, COA-verified products ready for your next study.

Common Questions About the MOTS-c Peptide

Reference:

• Reynolds, J.C., et al. (2021). MOTS-c is a mitochondria-derived peptide triggered by exercise that helps regulate age-related physical decline and maintain muscle balance.
• Pham, T., et al. (2025). Mitochondria-derived peptide MOTS-c restores mitochondrial respiration in type 2 diabetic hearts. Frontiers in Physiology, 16, 1602271.
• Zhong, Z., et al. (2022). MOTS-c protects against pressure overload-induced cardiac hypertrophy.
• Yin, X., et al. (2024). Mitochondrial-derived peptide MOTS-c suppresses ovarian cancer progression. Advanced Science.
• Frontiers in Physiology (2025). Mitochondria-derived peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes.